Alume Biosciences
Phase 3Before Surgery Patient receives ALM-488 through IV 60 minutes before surgery begins.
Founded
2017
Focus
OncologyDiagnostics
About
Before Surgery Patient receives ALM-488 through IV 60 minutes before surgery begins.
Funding History
2Total raised: $33M
Series A$25MRA Capital ManagementMay 15, 2023
Seed$8MUndisclosedSep 15, 2021
Company Info
TypePrivate
Founded2017
LocationSan Diego, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile